EGFR and non-small cell lung carcinoma: Here, single-nucleotide polymorphisms (SNP) in the EGFR signal pathway, as well as the drug metabolism and transport pathways, were investigated with next-generation sequencing (NGS) technologies to identify SNPs associated with drug responses to erlotinib in Chinese advanced NSCLC patients.